aMoon Fund

Make sure to check out Kyle LaHucik's article in Endpoints News, where he sat down with Dr. Reut Shema, Partner at aMoon, Cheng Zhang CEO of Character Biosciences, and Yehia Hashad MD, CMO of Bausch + Lomb to discuss this exciting investment! Yair Schindel, MD, MBA | Tomer Berkovitz | Todd Sone | Patrick Rivers | Ahuvit David | Gaby Hirsch | Cheng Zhang

Excited to add Character Biosciences to our Growth II Fund Portfolio!  One in eight people over the age of fifty suffer from age-related macular degeneration (AMD) - making this condition a leading cause of blindness globally. Often treated as a one-size-fits-all disease despite its complexity, and with very few treatment options, AMD has high failure rates in drug development, creating a huge unmet need. Leveraging proprietary AI-modeling, genomics, and longitudinal patient data to develop targeted therapies, Character is finally changing this paradigm.  aMoon Fund co-led this $93M Series B fundraising round alongside Luma Group, with participation from Jefferson Life Sciences and strategic Bausch + Lomb. Existing investors, including Innovation Endeavors, Catalio Capital Management, S32, and KdT Ventures, also joined the round. Reut Shema, PhD, Partner at aMoon, will be joining Character’s board to help drive their mission forward. At aMoon, we are driven to accelerate cure and help people live longer, better lives. Character Biosciences embodies this vision, and we are proud to be partnering with this exceptional team. Congratulations to the whole Character team on this exciting milestone, and welcome to the aMoon family! Thanks to Kyle LaHucik for the insightful piece about this news in Endpoints News: https://shorturl.at/hyptD Read the full press release here: https://bit.ly/4kVvXax #PrecisionMedicine #HealthTech #AMD #VentureCapital #Innovation Yair Schindel, MD, MBA | Tomer Berkovitz | Todd Sone | Patrick Rivers | Gaby Hirsch | Ahuvit David | Cheng Zhang | Laura Carter | Kaila Smilen | James Kasuboski | Themasap Khan, PhD | John Gomez | Laura Lande-Diner | Nick Olsen | Dror Berman | Joel Dudley | Nicholas von Guionneau, MD | Steve Kafka 

Thrilled to have you aboard! Looking forward to continuing our journey together. ✈️ Yair Schindel, MD, MBA | Tomer Berkovitz | Todd Sone | Tamir Maixner | Adam Kotzen

Today the aMoon Fund Israel team rolled up its sleeves and brightened the walls of the Maon Shikma Center, a wonderful 'mini-kibbutz' which cares for around 150 adults with cognitive and physical disabilities, providing round-the-clock care, rehabilitative therapies, and recreational activities in a beautiful pastoral setting in Ra'anana. Good Deeds Day was founded by Shari Arison, who since it's inception in 2007 has grown the project globally, with millions of people from over 100 countries uniting to create positive change and improve the lives of those within their local community. Thank you to Ruach Tova for all you do to create the opportunities for so many to volunteer and join the global movement of people and organizations dedicated to doing good every day.  #DoingGood #Impact #Teamwork

Last week, we had the privilege of hosting over 50 Decision Makers and Innovators at our Boston office, for a networking event, where meaningful conversations and connections took center stage. This event reminded us that successful innovation happens from the right partners asking thoughtful questions and bringing ideas to life. Some key takeaways: Innovators Panel: 1. Care models must prioritize whole-person, individualized approaches 2. Integration is critical - successful solutions fit seamlessly into both patient journeys and provider workflows 3. Bringing data back to providers and embedding within existing systems ensures long-term impact Decision Makers Panel: 1. Finding the right champion is key - identify the person with the power to say “yes” 2. Digital Health and Tech Enabled Service companies should look to their margins to sustain their claim that they are more of a tech company and less of a service company 3. Payors, initially reluctant to engage in pilots, are now refraining from it entirely and are instead looking for robust randomized controlled studies before committing to onboard new technologies A huge thank you to our partners LRVHealth and World 50 Group for co-hosting this important event. We’re excited to see the collaborations that grow from this event and continue shaping the future of specialty care! #HealthcareInnovation #SpecialtyCare #HealthTech #Collaboration Yair Schindel, MD, MBA | Tomer Berkovitz | Yaron Daniely | Yael Gruenbaum-Cohen | Reut Shema | Patrick Rivers | Gaby Hirsch | Tamir Maixner | Irena Katsman | Andrea Messina | David Twitchell | Najib Jai, MD, MBA | Kate Condliffe | Ellen Herlacher | Sandhya Rao | Stephanie Davis | Yehuda Kogan | Lin Health | Juliana Ekong | Better Life Partners | Jeff Sybesma | Josh Flum

Great to see the continued expansion of Better Life Partners, enabling more people to access to lifesaving care. Yair Schindel, MD, MBA | Tomer Berkovitz | Todd Sone | Tamir Maixner | Adam Kotzen | Gaby Hirsch | Juliana Ekong

Today marks the start of MIXiii Health-Tech.IL, Israel’s International Life Science & HealthTech Week, led by IATI - Israel Advanced Technology Industries Association. Over the course of the two days, industry leaders will dive into the latest trends and breakthrough technologies shaping the future of HealthTech. Vered Gigi, PhD, Principal at aMoon Velocity, will be speaking in a session titled: "Recent Advances and Innovations in Cancer Treatment." As a sneak peek Vered shared: "Oncology continues to be a leading therapeutic area for VCs, yet it is a very crowded market, leading to increased pressure for robust validation and differentiation. Aside from technological innovation around modalities and therapies, there is a continued and growing need for creative and efficient clinical design.” We look forward to engaging with our industry partners and driving innovation in the global HealthTech ecosystem. See you at MIXiii! Yair Schindel, MD, MBA | Tomer Berkovitz | Moshe Mor | Yaron Daniely | Roy Wiesner | Yael Gruenbaum-Cohen | Todd Sone | Reut Shema | Gaby Hirsch #HealthTech #Biotech #Innovation #Israel #MIXiii

Moore’s law is back! After redefining the genomics landscape with its $100 genome, Ultima Genomics continues to lead the way with additional throughput and cost advancements. Congratulations to the team on the commercial launch of the UG 100 Solaris, a major leap forward in sequencing technology. This innovation increases output by 50% and reduces costs by 20%, making whole genome sequencing possible for just $80. With enhanced sensitivity and efficiency, the #UG100 continues to push the boundaries of genomic data sequencing. We’re excited to see how this breakthrough shapes the future of genomics! Yair Schindel, MD, MBA | Tomer Berkovitz | Todd Sone | Tamir Maixner | Adam Kotzen | Gaby Hirsch | Gilad Almogy Read more here: https://lnkd.in/guwmSM5T

We are excited to welcome the new cohort for this years' LEAP program. Thank you to Inbal Sason and our partners 8200 Alumni Association Beilinson Innovation 8200Bio Israel Innovation Authority רשות החדשנות Medtronic and Microsoft for making this program possible. We look forward to seeing the innovations to come! Yair Schindel, MD, MBA | Yaron Daniely | Yael Gruenbaum-Cohen | Roy Wiesner | Moshe Mor

Exciting news from Theranica! The largest health insurer in Massachusetts recently published a positive reimbursement policy for Nerivio®, expanding coverage to an additional three million lives. Nerivio® is an FDA-cleared REN wearable for acute and preventive #migraine treatment, approved for adults and children ages 8 and up. This milestone is a game-changer for individuals who may struggle with side effects of medication, offering them a safe, effective, and drug-free alternative. We are proud to support Theranica as they continue to make Nerivio® easily accessible throughout the United States and beyond, helping people living with migraine get back on their feet. Read the full press release here: https://bit.ly/40W2OTq Yair Schindel, MD, MBA | Tomer Berkovitz | Todd Sone | Tamir Maixner | Adam Kotzen | Gaby Hirsch | Alon Ironi